![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Shohreh Issazadeh-Narvikas
shohreh.issazadeh@bric.ku.dk
453-532-5649
University of Copenhagen
Caption: When used in biological disease models, a kp7 vaccine prevents chronicity of inflammation in models of allergic asthma (AA), delayed-type hypersensitivity (DHT), multiple sclerosis (MS) and rheumatoid arthritis (RA). An antigen presenting cell (APC) takes up the kp7 molecules and present them to natural killer T-cells (NKT cells), which are activated to prevent chronic inflammation.
Credit: Shohreh Issazadeh-Narvikas/Steven Tresker
Usage Restrictions: credit should be given
Related news release: Vaccine boosts your immune system
|